eISSN 2508-3589
pISSN 2508-1926

Table. 2.

Table. 2.

Postoperative visual quality according to ERM stage (n = 289)

Variable No ERM (n = 228) Stage 1 (n = 29) Stage 2 (n = 20) Stage 3 (n = 12) p-value
Strehl ratio 0.03 ± 0.01 0.03 ± 0.01 0.02 ±0.01 0.03 ± 0.02 0.208
Area ratio, 4 mm 40.76 ± 9.47 42.70 ± 8.46 38.85 ± 5.80 37.75 ± 9.06 0.434
Area ratio, 5 mm 39.15 ± 8.27 40.29 ± 36.05 36.05 ± 5.07 35.40 ± 14.11 0.511
Ocular aberration
Total aberration 0.84 ± 0.29 0.77 ± 0.18 0.78 ± 0.22 0.98 ± 0.79 0.311
High order aberration 0.41 ± 0.15 0.38 ± 0.11 0.41 ± 0.11 0.40 ± 0.17 0.857
Coma 0.15 ± 0.10 0.13 ± 0.05 0.15 ± 0.08 0.16 ± 0.17 0.816
Trefoil 0.28 ± 0.17 0.25 ± 0.10 0.23 ± 0.13 0.31 ± 0.24 0.599
Spherical aberration 0.14 ± 0.08 0.13 ± 0.07 0.16 ± 0.06 0.13 ± 0.03 0.577
Contrast sensitivity
AULCSF, day* 1.48 ± 0.21 1.41 ± 0.18 1.33 ± 0.17 1.31 ± 0.19 0.036
AULCSF, night 1.21 ± 0.21 1.22 ± 0.12 1.02 ± 0.20 1.08 ± 0.10 0.027

Values are presented as mean ± standard deviation. Mann-Whitney test was used for the comparison.

ERM = epiretinal membrane; AULCSF = area under the logarithm of contrast sensitivity function; LSD = least significant difference.

*p = 0.285 for no ERM vs. stage 1 ERM, p = 0.060 for no ERM vs. stage 2 ERM, p = 0.028 for no ERM vs. stage 3 ERM, p = 0.424 for stage 1 vs. 2 ERM, p = 0.288 for stage 1 vs. 3 ERM, and p = 0.810 for stage 2 vs. 3 ERM (post hoc analysis using the LSD test); †p = 0.836 for no ERM vs. Stage 1 ERM, p = 0.010 for no ERM vs. stage 2 ERM, p = 0.086 for no ERM vs. stage 3 ERM, p = 0.029 for stage 1 vs. 2 ERM, p = 0.132 for stage 1 vs. 3 ERM, and p = 0.529 for stage 2 vs. 3 ERM (post hoc analysis using the LSD test).

J Retin 2024;9:24-33 https://doi.org/10.21561/jor.2024.9.1.24
© 2024 J Retin